borderline significantP = 0.052
Notably, in the VITACOG trial, aspirin use was also incidentally found to have a borderline significant negative interaction (P = 0.052) with B vitamins in slowing whole brain atrophy rate ( 7 ).
Notably, in the VITACOG trial, aspirin use was also incidentally found to have a borderline significant negative interaction (P = 0.052) with B vitamins in slowing whole brain atrophy rate ( 7 ).